Sökning: "martin gunnarsson"
Visar resultat 1 - 5 av 8 avhandlingar innehållade orden martin gunnarsson.
1. Efficient Security Protocols for Constrained Devices
Sammanfattning : During the last decades, more and more devices have been connected to the Internet.Today, there are more devices connected to the Internet than humans.An increasingly more common type of devices are cyber-physical devices.A device that interacts with its environment is called a cyber-physical device. LÄS MER
2. Security Solutions for Constrained Devices in Cyber-Physical Systems
Sammanfattning : Industrial Control Systems (ICS) are becoming more and more connected. Whileconnecting systems increases flexibility productivity in ICS, it also introduces risks and security vulnerabilities. Media have reported several cyberattacks against ICS, and security is a top priority in the next generation of ICS. LÄS MER
3. Chronic myeloid leukemia and cancer
Sammanfattning : Background Chronic myeloid leukemia (CML) is a relatively rare hematological malignancy with a constant incidence of approximately 90 new cases each year in Sweden (0.9 cases/100 000 inhabitants). The etiology is largely unknown but high doses of ionizing radiation are a known but rare risk factor. LÄS MER
4. Ancillary actor relations : The case of EU’s leading defence primes
Sammanfattning : This longitudinal research project in industrial marketing seeks to understand ancillary actors, specifically what they are, their characteristics, relations and impact on focal relations based on the empirical case of the cross-border relations of EU’s largest defence equipment producing firms (called “primes”). Ancillary actors are approached on four arenas: i) the political setting for EU defence equipment production, ii) the “primes” business relations, e. LÄS MER
5. Treatment with the monoclonal antibody rituximab in Multiple Sclerosis : a study based on an academic clinical trial
Sammanfattning : Background: Multiple sclerosis (MS) is a chronic, inflammatory disease, affecting the central nervous system. A growing number of disease modifying treatment alternatives entails a need for an individualised risk-benefit- convenience analysis in the counselling of patients and methods to monitor the treatment effect, including markers for subclinical inflammation. LÄS MER